| Q37412204 | A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice |
| Q81201365 | A protocol for determination of anticardiolipin antibodies by ELISA |
| Q57437612 | Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus |
| Q71018619 | Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome |
| Q40403484 | Anti-beta 2-glycoprotein I antibodies |
| Q28575717 | Anti-beta 2-glycoprotein I antibodies bind to central nervous system |
| Q33504706 | Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. |
| Q24561680 | Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids |
| Q40467271 | Anti-β2-Glycoprotein I antibodies and thrombosis |
| Q34504768 | Antibodies and vascular involvement in inflammatory joint disease: clinical relevance |
| Q33346329 | Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus |
| Q71828169 | Antibodies to beta 2-glycoprotein I and prothrombin in habitual abortion |
| Q77697679 | Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis |
| Q42084495 | Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface |
| Q40399658 | Antigenic specificities of "antiphospholipid" autoantibodies |
| Q71992282 | Antimitochondrial antibodies in the antiphospholipid syndrome |
| Q57825441 | Antiphospholipid Antibodies in Patients with Lupus Nephritis |
| Q36222874 | Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. |
| Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
| Q40506562 | Antiphospholipid antibodies and the antiphospholipid syndrome |
| Q33498510 | Antiphospholipid antibodies in pediatric lupus nephritis |
| Q41587414 | Antiphospholipid antibody syndrome in pediatric patients. |
| Q34271982 | Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis |
| Q36337350 | Antiphospholipid-related chorea. |
| Q41519678 | Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome. |
| Q40975353 | Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage |
| Q74211615 | Beta2-glycoprotein I-dependent and -independent anticardiolipin antibody in non-obese diabetic (NOD) mice |
| Q54483428 | Beta2GP-I in the anti phospholipid (Hughes') syndrome--from a cofactor to an autoantigen--from induction to prevention of antiphospholipid syndrome. |
| Q73264883 | Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot |
| Q30580637 | Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta2-glycoprotein I. |
| Q64948069 | Buffer may be the critical factor in measurement of anti-prothrombin antibody on a gamma-ray-irradiated plate by enzyme-linked immunosorbent assay. |
| Q48095095 | Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells |
| Q40841563 | Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects |
| Q35596537 | Dendritic cells, antibodies reactive with oxLDL, and inflammation. |
| Q74263564 | Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin |
| Q72002718 | Detection of anti-bovine ?2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome |
| Q73163209 | Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome |
| Q44428099 | Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients |
| Q22254095 | High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II |
| Q48001576 | Immunopurification of human beta2-glycorprotein I with a monoclonal antibody selected for its binding kinetics using a surface plasmon resonance biosensor |
| Q79293606 | Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? |
| Q33329907 | Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype |
| Q40544886 | Laboratory diagnosis of antiphospholipid syndromes. |
| Q35099172 | Laboratory diagnosis of the antiphospholipid syndrome |
| Q33376538 | Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies |
| Q33344207 | Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies |
| Q33333394 | Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies |
| Q73267440 | Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis |
| Q35399567 | Optimising testing for phospholipid antibodies |
| Q33498327 | Pathogenesis and treatment of the antiphospholipid antibody syndrome |
| Q40467263 | Physiopathology of thrombosis induced by antiphospholipid antibodies |
| Q77671181 | Pregnancy in women with systemic lupus erythematosus |
| Q40651854 | Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies |
| Q52957322 | Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. |
| Q46980324 | Prevalence of anticardiolipin and anti-beta2-glycoprotein I antibodies in celiac disease |
| Q33566956 | Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies |
| Q71992271 | Report of the First French Anticardiolipin Antibodies Standardization Workshop |
| Q74774458 | Role of anti-beta 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome |
| Q33489012 | Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells |
| Q77391585 | Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients |
| Q73523422 | Serum autoantibodies in patients with primary sclerosing cholangitis |
| Q79858058 | Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome |
| Q46349613 | Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to beta2glycoprotein I in patients with antiphospholipid syndrome |
| Q64964305 | Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays. |
| Q33497875 | The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays |
| Q28379106 | The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins) |
| Q41475203 | Thrombotic syndromes and autoimmune diseases |
| Q63681605 | Trousseau's syndrome with nonbacterial thrombotic endocarditis: Pathogenic role of antiphospholipid syndrome |
| Q77467515 | [Neurological manifestations of antiphospholipid syndrome] |
| Q73361307 | [New targets of antiphospholipid antibodies] |
| Q52081764 | beta2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss. |